Computing for Cures — BioCentury This Week television examines how advances in computer hardware and software are transforming drug development. With FDA CIO Eric Perakslis; Fred Streitz of Lawrence Livermore National Laboratory, and New York Genome Center COO Nancy Kelley.
Let BIO connect you with the global industry in 2013. BIO events help you raise capital from investors, engage potential partners with a unique set of industry leading attendees, and keep you at the forefront of sector trends, important catalysts and policy developments.
As part of its rigorous, scientific regulatory review governing genetically engineered (GE) animal technologies, the U.S. Food and Drug Administration (FDA) has released its draft Environmental Assessment of the genetically engineered (GE) AquAdvantage Salmon.
BIO announced that registration and housing are now open for the 2013 World Congress on Industrial Biotechnology and Bioprocessing. This unique conference will be held June 16-19, 2013 in Montreal, Canada at the Palais des congrès de Montréal.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.
Leveraging modern advancements in molecular biology and genomics, the Biotechnology Industry...
|
Executive Summary
At a time when the global economy struggles to recover from a severe...
|
Biotechnology is all around us and a big part of our lives, providing breakthrough products to...
|